Dong-A University Hospital
33
5
6
17
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
6.1%
2 terminated/withdrawn out of 33 trials
89.5%
+3.0% vs industry average
18%
6 trials in Phase 3/4
6%
1 of 17 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (33)
Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
Role: collaborator
Long-term Prospective Study of Korean CADASIL Patients
Role: collaborator
AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma
Role: collaborator
Clinical Study Evaluating the Proper Surgical Safety Margin for Early Stage Oral Tongue Cancers
Role: collaborator
Drug Response Testing and Repurposing Using Glioblastoma Organoid
Role: collaborator
Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma
Role: collaborator
Resting Full-cycle Ratio (RFR)-Guided Revascularization
Role: collaborator
Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM
Role: lead
Extension of Rapid Response Team Operation Time and Cardiopulmonary Resuscitation Incidence
Role: lead
Long-term KRd in Relapsed and/or Refractory Multiple Myeloma
Role: lead
Prognostic Impact of Lesion-specific Hemodynamic Index in Patients With Coronary Artery Disease
Role: collaborator
Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment
Role: collaborator
Impact of Coronary CT Angiography, Physiologic Assessment and Pharmacotherapy on the Clinical Outcomes
Role: collaborator
FOLFIRINOX for 2nd-line Treatment of BTC
Role: lead
Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation
Role: collaborator
Risk Stratification of Nodal PTCL
Role: collaborator
Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects
Role: lead
Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis
Role: collaborator
Marginal Zone Lymphoma Cohort in Korea
Role: lead
to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia
Role: collaborator